Moderna, Inc.
Biotechnology company · Cambridge, Massachusetts, United States · Nasdaq: MRNA
Moderna, Inc. is a biotechnology company headquartered in Cambridge, Massachusetts, United States. Its earliest recorded incorporation is in 2013. Its shares trade on Nasdaq under the ticker MRNA. It has reported private securities offerings to the US SEC, most recently $451 million sold in a notice filed in 2016.
What does Moderna do?
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $451.4 million sold (2016).
Frequently asked questions about Moderna
Where is Moderna headquartered?
Moderna, Inc. is headquartered in Cambridge, Massachusetts, United States.
What does Moderna do?
Moderna, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is Moderna a public company?
Yes. Moderna, Inc. trades on Nasdaq under the ticker MRNA.
When was Moderna founded?
The earliest incorporation on record for Moderna, Inc. is in 2013, according to public company registers.
Similar companies
- Editas Medicine, Inc.Cambridge, Massachusetts, United States
- Relay Therapeutics, Inc.Cambridge, Massachusetts, United States
- Beam Therapeutics Inc.Cambridge, Massachusetts, United States
- Epicore Biosystems, Inc.Cambridge, Massachusetts, United States
- Genzyme CorpCambridge, Massachusetts, United States
- Neutrolis Inc.Cambridge, Massachusetts, United States
- Biogen Inc.Cambridge, Massachusetts, United States
- Black Diamond Therapeutics, Inc.Cambridge, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.